Shimer Julie Ann 4

What Happened Julie Ann Shimer, a member of the board of directors of Avanos Medical, Inc. (AVNS), was granted 12,003 restricted share units (RSUs) on May 8, 2026. The grant is recorded as a derivative award at $0.00 per share because no cash changed hands at the time of grant. Each RSU represents a contingent right to receive a cash payment equal to the value of one Avanos common share upon settlement.

Key Details

• Transaction date and type: May 8, 2026 — Grant/Award (Form 4 code A) of 12,003 RSUs at $0.00 per unit.
• Filing: Reported on Form 4 filed May 12, 2026 (filed within the two-business-day window).
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes of note:
  • F1: These RSUs replace RSUs previously issued on January 2, 2025.
  • F2: The RSUs vest (become payable) on the date the reporting person terminates service on the Board — i.e., settlement is contingent on termination of board service.
• Settlement/derivative detail: These are cash‑settled RSUs (not stock immediately issued); value at settlement will equal the market value of Avanos common stock at that time.

Context Director RSU grants are common as board compensation and are different from purchases or sales of stock — they do not indicate immediate bullish or bearish trading by the insider. Because these RSUs are cash‑settled and vest only upon termination of board service, they function as deferred compensation rather than an active market transaction.